NeuBase Therapeutics Inc.

(NBSE) Trade

By |

Profile

NeuBase Therapeutics Inc is engaged in the development of gene silencing therapies with its synthetic antisense oligonucleotides. Its Patrol platform is focused on the development of drugs for rare genetic diseases such as Huntington's Disease, Myotonic Dystrophy and Familial Parkinson's Disease among others.

Contact Information

Website: www.neubasetherapeutics.com
Email: mrice@lifesciadvisors.com
Main Phone: +1 646 450-1790
Address: 700 Technology Drive
State: PA
City / Town: Pittsburgh
Country: USA
Postal Code: 15219

Issuer Information

Exchange: NSC
CEO: Dietrich Stephan
Employees: 3
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

NeuBase Therapeutics Inc is engaged in the development of gene silencing therapies with its synthetic antisense oligonucleotides. Its Patrol platform is focused on the development of drugs for rare genetic diseases such as Huntington's Disease, Myotonic Dystrophy and Familial Parkinson's Disease among others.

Contact Information

Website: www.neubasetherapeutics.com
Email: mrice@lifesciadvisors.com
Main Phone: +1 646 450-1790
Address: 700 Technology Drive
State: PA
City / Town: Pittsburgh
Country: USA
Postal Code: 15219

Issuer Information

Exchange: NSC
CEO: Dietrich Stephan
Employees: 3
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 5.95 $ 0.28 (4.94%)
Last Price 5.95 Change $ 0.28 Change % 4.94 Tick N/A
Bid 4.90 Bid Size 100.00 Ask 7.46 Ask Size 1,800.00
Open 5.51 High 6.00 Low 5.51 Prev Close 5.67
Last Trade Volume 83,278 52 Wk Hi 6.28 52 Wk Low 1.58
Market Cap 101.6 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 17,070,373.00 EPS (TTM) -2.36 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 0
Number of Buys 0 0
Number of Sells 0 0
Net Activity 0 0
Last 10 Buys Shares
Sam Backenroth 1,000
Jason Slakter 1,000
Orin Hirschman 1,000
Jason Slakter 1,000
Jason Slakter 1,000
Jason Slakter 1,000
Jason Slakter 1,000
Jason Slakter 1,000
Jason Slakter 1,000
Sam Backenroth 1,000
Last 10 Sell Shares
N/A 0
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 0.4 0.4 0.4 0.4
Low Target Price Estimate 0.4 0.4 0.4 0.4
Mean Target Price Estimate 0.4 0.4 0.4 0.4
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 05/31/18 05/31/18 05/31/18 05/31/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 0 0 0 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 3